Abstract. Side population (SP) cells are a small subpopulation of cells found in many mammalian tissues and organs, identified by their capacity to efflux Hoechst 33342 dye. They are enriched for stem/progenitor cell activity. SP cells isolated from the adult mouse lung can be separated into a CD45 + subset (bone marrow-derived) and a CD45 -subset that can be subdivided into cd31 - 
Introduction
Chronic pulmonary diseases, including pulmonary hypertension, chronic obstructive pulmonary disease and interstitial pulmonary fibrosis, constitute major contributors to morbidity and mortality rates (1, 2) . The use of stem cells for cell-based therapy in chronic pulmonary diseases has been under investigation (3) (4) (5) (6) (7) (8) . In previous years, different populations of lung stem-or progenitor-cells have been reported to reside within the adult mouse lung. They are thought to be involved in tissue maintenance and repair, however, they may also contribute to pulmonary diseases (4, 5, 8) . Using different markers and methods, these cells have been variously described as: i) Airway clara cells (9) , ii) alveolar type II cells (10) , iii) lung c-kit positive cells (11, 12) , and iv) lung side population (LSP) cells (13) (14) (15) (16) . SP cells are identified by their capacity to efflux Hoechst 33342 dye, allowing the weakly-labeled SP cells to be distinguished from the intensely-labeled main population (MP) of cells (17) (18) (19) . This unique property is mediated through the action of the p-glycoprotein multidrug/ATP-binding cassette transporter protein, ATP-binding cassette super-family G member 2 (ABCG2) on the surface of SP cells, which pumps Hoechst dye out of the cell (20, 21) . SP cells have been found in numerous adult mammalian tissues and organs, including
Differentiation of CD45 -/CD31
+ lung side population cells into endothelial and smooth muscle cells in vitro bone marrow, the heart, liver, skeletal muscle, brain, kidney and lung (14, 19, (21) (22) (23) . These cells are rare and they are enriched for stem/progenitor cell activity.
Several studies have suggested that LSP cells are capable of differentiation into epithelial cells, endothelial cells, smooth muscle cells and mature hematopoietic cells (13) (14) (15) (16) 24) . LSP cells are known to be heterogeneous (13, 14, 24, 25) . Based on their expression of CD45, LSP cells can be separated into CD45 + and CD45 -subpopulations. CD45 + LSP cells possess hematopoietic progenitor and stem cell activity, and are most likely bone marrow-derived (14, 24) . By contrast, CD45
-LSP cells can be further divided into CD45 -/cd31 -and CD45 -/cd31 + subpopulations (15, 24) . The CD45 -/cd31 -subpopulation has been shown to comprise resident mesenchymal progenitor cells, capable of differentiating in vitro into cartilage, bone and adipose cells (15) . However, the nature and differentiation potential of CD45 -/cd31 + LSP cells remain to be fully elucidated. Our previous study demonstrated that CD45 -LSP cells may be progenitors of endothelial and smooth muscle cells in the embryonic mouse lung (14, 24) . In addition, it has been suggested that mouse heart and lung tissues, including blood vessel cells, may share a novel population of progenitor cells (26) . In the adult mouse heart, the stem cell antigen-1 (ScA1) + /cd31 + subpopulation of cardiac SP (CSP) cells have been reported to be endothelial progenitors (27, 28 -/cd31 + LSP cells in the adult mouse lung, to clarify their differentiation potential, and to examine the association between these two types of LSP cells in vitro.
Materials and methods
Animals. Female wild-type C57BL/6J mice (aged 8-10 weeks, weighting 22-25 g) were purchased from Beijing HFK-Biotechnology (Beijing, China). The mice were group-housed in individually-ventilated cages under pathogen-free conditions. The mice were maintained under a 12 h light/dark photoperiod, at 20±1˚C with 60±10% relative humidity and food and water were provided ad libitum. The general health status of the animals was monitored daily. Animal care, handling and all animal experiments described herein were conducted strictly according to ethical standards approved by the Animal Ethical Committee of Jinzhou Medical University (Jinzhou, China; approval ID: LY2014D001).
CD45
-/CD31 + LSP cell isolation, fluorescence-activated cell sorting (FACS) and analysis. The LSP cells were isolated as previously described (14, 15, 28, 29) . Briefly, the mice were sacrificed by isoflurane anesthesia followed by cervical dislocation. Prior to lung extraction, animals were bled by transecting the abdominal aorta. Subsequently, in an attempt to remove circulating blood cells, perfusion of the pulmonary vasculature was performed using ice-cold saline until the lungs were bleached white. The lung extracts were then digested by finely mincing tissue with a razor blade in the presence of 0.1% collagenase (Roche Diagnostics, Indianapolis, IN, USA), 2.4 U/ml dispase (Roche Diagnostics), and 2.5 mM CaCl 2 at 37˚C for 1 h. Removal of nonspecific debris was accomplished by sequential filtration through 70-and 40-µm filters, and the cells were resuspended at a density of 1x10 6 cells/ml. Cell staining was performed by incubating with Hoechst 33342 (5 µg/ml; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at 37˚C for 90 min in the presence or absence of verapamil (50 mM; Sigma-Aldrich; Merck KGaA) (21) . The suspension was subsequently incubated with one or more fluorescently-conjugated monoclonal rat anti-mouse antibodies, including anti-CD45-PerCP-Cy5. 5 The following six parameters were used to discriminate cells in the experiments: Hoechst 33342 (red), Hoechst 33342 (blue), forward scatter, side scatter, PerCP-Cy5.5-CD45, FITC-SCA1 and PE-CD31 reactivity (green) as previously described (14, 27, 30) . This protocol is illustrated in Fig. 1 To promote smooth muscle growth and differentiation, the CD45 -/cd31 + /VEGFR2 -LSP cells were cultured with a defined smooth muscle differentiation medium (SmGm-2) from Cambrex supplemented with 100 U/ml of penicillin (Invitrogen; Thermo Fisher Scientific, Inc.), and 100 µg/ml of streptomycin (Invitrogen; Thermo Fisher Scientific, Inc.). The culture medium was replaced every 2 days. Following 14 days in culture, the cells were collected for RT-qPCR and immunostaining analyses. To determine whether the CD45 -/cd31 + /VEGFR2 + LSP cells were able to differentiate into smooth muscle cells, they were cultured in the medium described above for 14 days and were then harvested for RT-qPCR analysis.
Cell line culture. The HepG2 human liver cancer cell line, obtained from American Type culture collection (Manassas, VA, USA), was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% GIBCO ® fetal calf serum, 100 U/ml of penicillin, and 100 µg/ml of streptomycin (all from Invitrogen; Thermo Fisher Scientific, Inc.) at 37˚C in a 5% CO 2 incubator.
Cellular uptake of Dil-labeled acetylated low-density lipoprotein (Dil-Ac-LDL). The CD45
-/cd31 + LSP cells at a density of 7,000 cells/well were incubated with EGM-2 containing 10 mg/ml of Dil-Ac-LDL (Molecular Probes; Thermo Fisher Scientific, Inc.) at 37˚C for 8 h as previously described (28) . Following washing with PBS, the cells were fixed and nuclei were counterstained with 4-6-diamidino-2-phenylindol-dihydrochloride (DAPI). The slides were examined using an Olympus-DP70 microscope and images were captured with a digital camera (BX51; Olympus Corporation, Tokyo, Japan). HepG2 cells were included to provide a negative control for Ac-LDL uptake.
Methylcellulose assay (colony-forming unit assay). The CD45
-/cd31 + LSP and LMP cells (7,000 cells/ml) were cultured in Methocult GF M3534 medium according to the manufacturer's protocol (StemCell Technologies, Inc., Vancouver, Canada) as described previously (17, 19, 27, 28) . Cell colonies, consisting of >30 cells, were scored after 14 days in culture. The cell colonies were fixed with 4% paraformaldehyde and stained with crystal violet based on the manufacturer's protocol (Sigma-Aldrich; Merck KGaA). Photomicrographs were obtained, from which the colonies were counted using an Olympus-DP70 microscope and images were captured with a digital camera (BX51). In order to determine whether the cells retained their CD45 -/cd31 + LSP phenotype, Methoult medium was cut into sections and these were incubated with DMEM at 37˚C with agitation for 30 min. When the Methocult medium had dissolved in the DMEM, the cells were collected, labeled with the CD45-PerCP-Cy5.5 (1:100), CD31-PE (1:100) and SCA1-FITC (1:100) antibodies, and analyzed by FACS.
RT-qPCR analysis. Total RNA was extracted from the freshly isolated distinct LSP, LMP and cultured cells using an RNAeasy-Mini kit, following the manufacturer's protocol (Qiagen GmbH, Hilden, Germany). Complementary DNA was generated using an M-MLV MicroRNA Reverse Transcription kit (Promega Corporation, Madison, WI, USA). RT-qPCR analysis was performed as previously described using a Rotor-gene 3000 machine (Corbett; Qiagen GmbH) with a SYBR-Green qPCR-SuperMix-UDG kit (Thermo Fisher Scientific, Inc.) following the manufacturer's protocol. commercial primer sets were obtained from Qiagen GmbH, as follows: ATP-binding cassette super-family G member 2 (ABCG2; cat. no. QT00173138), CD133 (cat. no. QT01065162), VEGFR2 (cat. no. QT00097020), von Willebrand factor (vWF; cat. no. QT00116795), α-smooth muscle tropomyosin (αSMT; cat. no. QT00137354), α-smooth muscle actin (αSMA; cat. no. QT0006746), CD44 (cat. no. QT00173404), myosin heavy chain (cat. no. QT01558130) and β-actin (cat. no. QT01136772). qPCR was performed in a 20-µl reaction system, which contained 10 µl SYBR-Green qPCR-SuperMix-UDG (Thermo Fisher Scientific, Inc.), 2 µl cDNA, 0.4 µl each primer and 7.2 µl RNase-free H 2 O. The thermal cycler conditions were performed as follows: Cycle 1 (95˚C for 3 min), Cycle 2 (35 cycles of 95˚C for 30 sec, 57˚C for 30 sec, 72˚C for 30 sec), Cycle 3 (72˚C for 4 min), which was based on the manufacturer's protocol (31) . All samples were amplified in triplicate. Amplification data were analyzed with Corbett Rotor-gene 3000 software (Qiagen GmbH) as described previously (27, 28) . The relative mRNA expression levels of the genes mentioned above were normalized against the expression of housekeeper gene β-actin and calculated using the 2 -ΔΔCq method as previously described (28, 31, 32) . Gene expression data are presented in relative units.
Immunofluorescence staining of isolated and cultured cells. For analysis of the sorted cells, 1,000 CD45
-/cd31 + /VEGFR2 -LSP cells, CD45 -/cd31 + /VEGFR2 + LSP cells and CD45 -LMP cells were collected onto positively charged slides by cyto-centrifugation at 60 x g for 5 min at room temperature prior to air-drying. The slides were then fixed for 10 min in 4% paraformaldehyde/PBS, washed with 1X PBS, air dried and stored at 4˚C prior to staining. The cultured monolayer cells were fixed and prepared for staining using the same procedure. Immunofluorescence staining was performed as previously described (14) . Autofluorescence was first quenched with 10 mM sodium borohydride for 30 min at room temperature. Nonspecific binding was blocked by incubating with 1% rabbit serum (cat. no. ab7356; Abcam, Cambridge, MA, USA) or goat serum (cat. no. ab7487; Abcam). The primary antibodies used included monoclonal rat anti-mouse ABCG2 (1:100; cat. no. ab24115; Abcam), polyclonal rabbit anti-mouse vWF (1:100; cat. no. AB7356; Chemicon, Temecula, CA, USA), monoclonal anti-mouse αSMA-Cy3 (1:100; cat. no. C-6198; Sigma-Aldrich; Merck KGaA) and polyclonal rabbit anti-mouse αSMT (1:100; cat. no. T3651; Sigma-Aldrich; Merck KGaA). Secondary antibodies included rabbit anti-rat IgG-FITC (1:200; cat. no. ab6730-1; Abcam), goat anti-rabbit IgG-594 (1:200; cat. no. A11012; Invitrogen; Thermo Fisher Scientific, Inc.) and donkey anti-rabbit IgG-FITC (1:200; cat. no. A21206; Invitrogen; Thermo Fisher Scientific, Inc.). All incubations of primary and secondary antibodies were performed for 60 and 30 min at 4˚C in the dark, respectively. The nuclei were counterstained with DAPI. Slides were examined using an Olympus-dP70 microscope and images were captured with a digital camera (BX51).
Statistical analysis. Data are presented as the mean ± standard deviation. Student's t-test (two-tailed unpaired) was used to analyze experimental data containing two groups, and one-way analysis of variance with the Bonferroni post hoc test was used to analyze experimental data with ≥3 groups. Statistical analysis was performed using SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference. Each experiment was repeated three times to obtain the means used for statistical analysis (n=3 experiments) as previously described (28) .
Results

LSP cell populations
Identification, isolation and gene expression. The adult mouse lungs were enzymatically digested into single cell suspensions and subjected to FACS analysis (Fig. 1) . The LSP cells were detected on density dot plots based on their capacity to efflux Hoechst 33342 dye. Those cells that were weakly labeled for Hoechst 33342 dye (LSP cells) represented ~0.7% of the total cell population ( Fig. 2A) . The LSP population disappeared when the ABCG2 transporter was blocked with verapamil (Fig. 2B) . The LSP cells were first separated into CD45 + (~54% of total LSP cells) and CD45 -(~46% of total LSP cells) subpopulations as previously described (14) (Fig. 2C) (Fig. 2G and H) . Based on their immune-phenotype, CD45
-/cd31 + LSP, (Fig. 2) .
In our previous study, it was found that CD31 + cSP cells are endothelial progenitors of adult mouse heart (27) . Therefore, the present study aimed to further characterize CD45 -/cd31 + /VEGFR2 -and CD45 -/cd31 + /VEGFR2 + LSP cells by examining the expression of genes specific for stem/progenitor cells and endothelial cells, using RT-qPCR analysis. As expected, the CD45 -/cd31 + /VEGFR2 -and CD45 -/cd31 + /VEGFR2 + LSP cells expressed high mRNA levels of the ABCG2 transporter, which is responsible for the efflux of Hoechst 33342 dye (20) . Both also expressed CD133, a marker for endothelial progenitor cells (33) . By contrast, the CD45 -LMP cells expressed neither ABCG2 nor CD133. VEGFR2, a marker of endothelial cells, and vWF, a mature endothelial cell marker, were just detectable in the CD45 -/cd31 + /VEGFR2 + LSP cells but not in the CD45 -/cd31 + /VEGFR2 -LSP cells (Fig. 3A) . CD45 -LMP cells, serving as a positive control, expressed high levels of VEGFR2 and vWF (Fig. 3A) . The CD45 -LMP cells also expressed high levels of mRNAs encoding αSMA, a marker of smooth muscle progenitors (24, 34) , αSMT, a marker of mature smooth muscle cells (24, 34) (Fig. 3A) , suggesting (Fig. 3B-E) . By contrast, the CD45 -LMP cells expressed vWF protein, but not the ABCG2 transporter (Fig. 3F and G) (Fig. 4A-D) supports this notion.
In vitro colony-formation by CD45
-/CD31 + LSP cells. Our previous study showed that CD31 + cSP cells were able to form colonies in vitro (27) . Therefore, the present study examined the in vitro colony-forming potential of CD45 -/cd31 + LSP cells. LMP and LSP cells freshly isolated from adult murine lungs were plated on methylcellulose media. After 14 days in culture, the number of colonies was counted. A typical colony formed Fig. 5A and B, respectively. Compared with the CD45 -/cd31 + LMP cells, the CD45 -/cd31 + LSP cells produced more colonies (Fig. 5C-E) . FACS analysis of the LSP cells that were subsequently isolated from the methylcellulose media revealed surface expression of CD31 (100%) and SCA1 (100%), but not CD45, indicating that the colony forming cells had retained their phenotype following culture (Fig. 5F-H (Fig. 6A and B During this culture, the CD45 -/cd31 + /VEGFR2 -LSP cells showed significant reductions in the mRNA expression levels of ABCG2 and CD133, with levels becoming similar to those found in freshly isolated CD45 -/cd31 + /VEGFR2 + LSP cells (Fig. 6D) (Fig. 6D) .
The expression of αSM A by freshly isolated CD45 -/cd31 + /VEGFR2 -LSP cells suggested that they may serve a role as smooth muscle progenitors. To investigate this, the CD45 -/cd31 + /VEGFR2 -LSP cells were cultured in medium previously shown to promote smooth muscle differentiation (24) . After 14 days in culture, many of the cells had developed the morphologic characteristics of smooth muscle cells, being large, flat, and stellate in appearance, and showing uniform immunostaining for αSMA and αSMT (Fig. 7A-F) . To extend these findings, the gene expression profiles of freshly isolated and cultured CD45 -/cd31 + /VEGFR2 -LSP cells were compared. The mRNA expression of ABCG2 and CD13 was detected in the freshly isolated CD45 -/cd31 + /VEGFR2 -LSP cells, however, the expression of these two genes was no longer detectable following 14 days in smooth muscle medium (Fig. 7G) . By contrast, the CD45 -/cd31 + /VEGFR2 -LSP cells showed significantly upregulated expression levels of αSMA following 14 days in smooth muscle media, resulting in levels similar to those in the freshly isolated CD45 -LMP cells (Fig. 7G) . Following 14 days of culture in smooth muscle differentiation medium, the mature smooth muscle markers, αSMT and myosin heavy chain (35) were expressed by the 14-day-cultured CD45 -/cd31 + /VEGFR2 -LSP cells and freshly isolated CD45 -LMP cells, but not by the freshly isolated CD45 -/cd31 + /VEGFR2 -LSP cells (Fig. 7G) . By contrast, the CD45 -/cd31 + /VEGFR2 + LSP cells did not express detectable mRNA levels of αSMA, αSMT or myosin heavy chain either before or after 14 days in smooth muscle differentiation medium (Fig. 7G) . Therefore, although CD45 -/cd31 + /VEGFR2 -LSP cells may be smooth muscle progenitor cells, the CD45 -/cd31 + /VEGFR2 + LSP cells showed no such potential.
Discussion
There have been several reports of the existence of endogenous stem cell-like cell populations in the mouse lung (14, 25 (27, 37) . By contrast, the CD45 -/cd31 + /VEGFR2 + LSP cells expressed detectable levels of vWF and VEGFR2, but no αSMA, indicating that these cells may be relative late commitment endothelial progenitor cells.
The results of the present study showed that CD45 -/cd31 + LSP cells possessed a higher colony-forming potential than CD45 -/cd31 + LMP cells. This finding is consistent with previous studies that reported SP cells isolated from different tissues have higher colony-forming capability than non-SP cells (19, 27, 38) . A previous study showed that a small number of cells isolated from the CD31 + population from the adult mouse lung were endothelial progenitor cells (39) . This group of endothelial progenitor cells may be CD45 -/cd31 + LSP cells. However, the data obtained in the present study do not rule out the possibility that other populations of CD31 + cells function as endothelial progenitor cells.
In a previous study, Irwin et al (16) , including surface expression of SCA1, similarity in gene expression profiles, capacity for colony formation and potential for endothelial differentiation (27, 28) . Our findings support the hypothesis that a novel population of progenitor cells may contribute to heart and lung tissues, including their blood vessels (26) . Our previous study also demonstrated that vascular smooth muscle and airway smooth muscle share a common progenitor cell in the lung. Further investigation is required to determine whether CD45 -/cd31 + /VEGFR2 -LSP cells differentiate into airway smooth muscle cells. Previous studies have found that c-kit + cells in the adult mouse lung may serve as endothelial progenitor cells (11) . However, the expression of c-kit was undetectable in CD45 -/cd31 + LSP cells. Therefore, the association between lung c-kit cells and CD45 -/cd31 + LSP cells also requires further investigation.
In conclusion, the present study isolated and characterized CD45 -/cd31 + SP cells from the adult mouse lung. 
